US PRE-MARKET MOVERS: MBLY, MSTR, MCD, AIR, VTYX, STAA, META, LOW, JPM, CSGP

US PRE-MARKET MOVERS: MBLY, MSTR, MCD, AIR, VTYX, STAA, META, LOW, JPM, CSGP

• Mobileye (MBLY) surges 11% on acquisition news, while Ventyx Biosciences (VTYX) jumps 59% amid acquisition talks with Eli Lilly (LLY).
• Staar Surgical (STAA) drops 7% following the termination of its merger agreement with Alcon (ALC).
• CoStar Group (CSGP) falls 1.6% after a disappointing revenue outlook, despite announcing a $1.5 billion share buyback programme.

In the pre-market session, several stocks are experiencing notable movements driven by corporate actions and analyst ratings. Mobileye (MBLY) is up 11% following its announcement to acquire humanoid robotics startup Mentee Robotics for approximately $900 million. This acquisition is seen as a strategic move to enhance Mobileye's capabilities in autonomous driving technology, potentially positioning it as a leader in the integration of robotics and AI within the automotive sector.

Ventyx Biosciences (VTYX) has surged 59% as reports indicate that Eli Lilly (LLY) is in advanced talks to acquire the company for over $1 billion. This potential acquisition highlights the ongoing consolidation in the biotech sector, as larger pharmaceutical companies seek to bolster their pipelines with innovative therapies.

On the downside, Staar Surgical (STAA) has declined 7% after Alcon (ALC) terminated its definitive merger agreement with the company. The termination of this agreement has raised concerns about Staar Surgical's strategic direction and future growth prospects without the anticipated synergies from the merger.

CoStar Group (CSGP) is down 1.6% after issuing a full-year revenue outlook that marginally disappointed investors. Despite this, the company announced a $1.5 billion share buyback programme, which some market participants may view as a signal of confidence in its long-term prospects.

In other notable movements, MicroStrategy (MSTR) is up 4.5% after MSCI confirmed that it will not exclude Digital Asset Tokens (DATs) from its Global Investable Market Indexes in the February review. This decision is seen as a positive development for companies with significant cryptocurrency holdings.

McDonald's (MCD) and Lowe's (LOW) have both received upgrades, with MCD up 0.5% following an upgrade at Oppenheimer and LOW rising 1.6% after a Barclays upgrade. Conversely, JPMorgan Chase (JPM) is down 0.4% after being downgraded by Wolfe Research.

Meta Platforms (META) is slightly down by 0.4% as Chinese officials review its $2 billion purchase of AI start-up Manus, reflecting ongoing regulatory scrutiny in cross-border tech acquisitions.

Trader Insight:
Market participants are closely monitoring MBLY following its acquisition announcement, as it may influence sentiment in the autonomous vehicle sector. Traders are also observing VTYX amid acquisition talks with LLY, which could impact biotech stocks. The termination of STAA's merger agreement with ALC is prompting discussions about potential volatility in the medical devices sector. Additionally, CSGP's share buyback programme is being watched for its potential impact on stock price stability. In the currency markets, the decision by MSCI regarding DATs may lead traders to reassess their positions in cryptocurrencies like BTC and ETH.

Disclaimer: This is not trading advice. For informational purposes only.